Curcumin as a Complementary Treatment in Cancer Therapy: A Comprehensive Review

Jenn Hoskins
20th October, 2024

Curcumin as a Complementary Treatment in Cancer Therapy: A Comprehensive Review

Curcumin

Wikimedia Commons / CC0

Key Findings

  • The study reviewed 34 trials with 2580 cancer patients, mainly with head and neck cancer, to assess curcumin's effects
  • Curcumin showed potential in reducing oral mucositis and aiding faster recovery from chemotherapy-induced oral mucositis
  • Curcumin did not significantly improve body composition or weight but helped slow muscle strength loss and basal metabolic rate decline in cancer patients
Curcumin, the active compound found in turmeric, has gained attention for its potential benefits in supporting conventional cancer therapies. This systematic review conducted by Universitätsklinikum Jena aims to provide a comprehensive overview of the clinical evidence related to curcumin supplementation in cancer patients[1]. The review included 34 randomized controlled trials involving 2580 patients, primarily diagnosed with head and neck cancer, followed by breast, prostate, and colorectal cancers. The trials evaluated both topical and systemic administration of curcumin. The primary focus was on the effects of curcumin on oral and skin symptoms, pain, weight alteration, body composition, survival, and disease progression. Significant findings were reported for oral mucositis and weight loss, although the results were heterogeneous, and all studies had a moderate to high risk of bias. Curcumin has been extensively studied for its various health benefits, including its antioxidant, anti-inflammatory, neuroprotective, anticancer, hepatoprotective, and cardioprotective effects[2]. Despite its potential, the bioavailability of curcumin remains a challenge, which may affect its clinical efficacy. In the context of cancer therapy, curcumin's role has been explored in several areas. One notable study investigated the effect of curcumin on cancer anorexia-cachexia syndrome (CACS), a condition characterized by severe weight loss and muscle wasting in cancer patients. The study found that curcumin did not significantly improve body composition or weight compared to placebo. However, it did show some benefits in slowing the progression of hand-grip muscle strength loss and basal metabolic rate[3]. These findings suggest that while curcumin may not drastically alter body composition, it could provide some functional benefits for cancer patients. Another study focused on the use of curcumin for treating chemotherapy-induced oral mucositis, a common and painful side effect of cancer treatment. The results indicated that curcumin could lead to faster recovery compared to mucosamin and chlorhexidine, highlighting its potential as a viable intervention for improving the quality of life in cancer patients[4]. This aligns with the findings of the systematic review, which also reported significant improvements in oral mucositis with curcumin supplementation. Additionally, curcumin's antioxidant properties have been evaluated in prostate cancer patients undergoing radiotherapy. The study showed that curcumin supplementation increased plasma total antioxidant capacity and decreased the activity of superoxide dismutase, an enzyme involved in oxidative stress. While both the curcumin and placebo groups showed reduced PSA levels, indicating effective cancer treatment, curcumin demonstrated additional benefits in enhancing the body's antioxidant status[5]. Despite these promising findings, the systematic review highlighted the need for higher quality studies to derive a definitive recommendation for curcumin use in cancer therapy. The heterogeneous results and methodological limitations of the included studies underscore the necessity for more rigorous research to confirm curcumin's efficacy and safety. In conclusion, while curcumin shows potential in reducing oral mucositis and weight loss in cancer patients, the current evidence is not sufficient to make a clear recommendation. Further high-quality studies are essential to better understand the benefits and risks of curcumin supplementation in cancer therapy.

MedicineHealthBiochem

References

Main Study

1) Curcumin as a complementary treatment in oncological therapy: a systematic review.

Published 19th October, 2024

https://doi.org/10.1007/s00228-024-03764-9

Related Studies

2) Turmeric and Its Major Compound Curcumin on Health: Bioactive Effects and Safety Profiles for Food, Pharmaceutical, Biotechnological and Medicinal Applications.

https://doi.org/10.3389/fphar.2020.01021

3) A Double-Blind, Placebo-Controlled Randomized Phase IIa Study: Evaluating the Effect of Curcumin for Treatment of Cancer Anorexia-Cachexia Syndrome in Solid Cancer Patients.

https://doi.org/10.31557/APJCP.2022.23.7.2333

4) A comparative study to assess the effectiveness of curcumin, mucosamin, and chlorhexidine in chemotherapy-induced oral mucositis.

https://doi.org/10.1016/j.explore.2022.04.009

5) Effect of Curcumin Supplementation During Radiotherapy on Oxidative Status of Patients with Prostate Cancer: A Double Blinded, Randomized, Placebo-Controlled Study.

https://doi.org/10.1080/01635581.2016.1115527


Related Articles

An unhandled error has occurred. Reload đź—™